CLINICAL_TRIALS
trial_result
· 2020-07-30
Clinical Trial Update: Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease [Phase 2]
Summary
Phase 2 clinical trial update for ladostigil in mild to moderate probable Alzheimer's disease completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avraham Pharmaceuticals Ltd | Conditions: Alzheimer's Disease, Dementia | Phase 2 | Status: COMPLETED | Results posted: 2020-07-30